H.B. Fuller (NYSE:FUL - Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 3.840-3.840 for the period, compared to the consensus estimate of 4.160. The company issued revenue guidance of $3.6 billion-$3.6 billion, compared to the consensus revenue estimate of $3.6 billion.
H.B. Fuller Price Performance
Shares of FUL stock traded down $5.09 during trading hours on Thursday, hitting $62.39. 797,762 shares of the company's stock were exchanged, compared to its average volume of 233,160. H.B. Fuller has a fifty-two week low of $61.71 and a fifty-two week high of $87.67. The firm has a market cap of $3.41 billion, a P/E ratio of 19.26, a P/E/G ratio of 1.24 and a beta of 1.41. The company has a quick ratio of 1.16, a current ratio of 1.89 and a debt-to-equity ratio of 1.10. The firm has a 50 day moving average of $73.57 and a two-hundred day moving average of $77.91.
Analysts Set New Price Targets
Several equities analysts have issued reports on the stock. StockNews.com downgraded shares of H.B. Fuller from a "buy" rating to a "hold" rating in a report on Wednesday, September 18th. Citigroup lowered their price objective on H.B. Fuller from $85.00 to $78.00 and set a "neutral" rating on the stock in a report on Wednesday, December 18th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, H.B. Fuller currently has an average rating of "Hold" and a consensus price target of $92.75.
View Our Latest Stock Analysis on FUL
H.B. Fuller Company Profile
(
Get Free Report)
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
Further Reading
Before you consider H.B. Fuller, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and H.B. Fuller wasn't on the list.
While H.B. Fuller currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.